The desmoplastic stroma of pancreatic cancer is a barrier to immune cell infiltration

OncoImmunology

Volumn 2, Issue 12, 2013, Pages

  Watt, Jennifer ^a,b   Kocher, Hemant M ^a,b  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b ROYAL LONDON HOSPITAL   (United Kingdom)

Author keywords

B cells; CD8+ T cells; Macrophages; Natural killer cells; Neutrophils

Indexed keywords

BLINATUMOMAB; CD137 LIGAND; CD19 ANTIBODY; CD3 ANTIBODY; CD33 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 2; SINGLE CHAIN FRAGMENT VARIABLE ANTIBODY; T LYMPHOCYTE RECEPTOR; TUMOR ANTIGEN; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR SUPERFAMILY MEMBER 9; UNCLASSIFIED DRUG;

ACUTE GRANULOCYTIC LEUKEMIA; ARTICLE; CD3+ T LYMPHOCYTE; CELL INTERACTION; HUMAN; IN VITRO STUDY; IN VIVO STUDY; PROSTATE CARCINOMA; SJOEGREN SYNDROME; T LYMPHOCYTE ACTIVATION; TUMOR IMMUNITY;

EID: 84896732545     PISSN: 21624011     EISSN: 2162402X     Source Type: Journal    
DOI: 10.4161/onci.26788     Document Type: Article

References (9)

1. Apte MV, Wilson JS, Lugea A, Pandol SJ. A starring role for stellate cells in the pancreatic cancer microenvironment. Gastroenterology 2013; 144:1210-9; PMID:23622130; http://dx.doi.org/10.1053/j. gastro.2012.11.037
2. Kadaba R, Birke H, Wang J, Hooper S, Andl CD, Di Maggio F, Soylu E, Ghallab M, Bor D, Froeling FE, et al. Imbalance of desmoplastic stromal cell numbers drives aggressive cancer processes. J Pathol 2013; 230:107-17; PMID:23359139; http://dx.doi. org/10.1002/path.4172
3. Froeling FE, Feig C, Chelala C, Dobson R, Mein CE, Tuveson DA, Clevers H, Hart IR, Kocher HM. Retinoic acid-induced pancreatic stellate cell quiescence reduces paracrine Wnt-ß-catenin signaling to slow tumor progression. Gastroenterology 2011; 141:1486-97, e1-14; PMID:21704588; http://dx.doi. org/10.1053/j.gastro.2011.06.047
4. Pérez-Mancera PA, Guerra C, Barbacid M, Tuveson DA. What we have learned about pancreatic cancer from mouse models. Gastroenterology 2012; 142:1079-92; PMID:22406637; http://dx.doi. org/10.1053/j.gastro.2012.03.002
5. Feig C, Gopinathan A, Neesse A, Chan DS, Cook N, Tuveson DA. The pancreas cancer microenvironment. Clin Cancer Res 2012; 18:4266-76; PMID:22896693; http://dx.doi.org/10.1158/1078-0432.CCR-11-3114
6. Ricci F, Kern SE, Hruban RH, Iacobuzio-Donahue CA. Stromal responses to carcinomas of the pancreas: juxtatumoral gene expression conforms to the infiltrating pattern and not the biologic subtype. Cancer Biol Ther 2005; 4:302-7; PMID:15876873; http:// dx.doi.org/10.4161/cbt.4.3.1501
7. Ene-Obong A, Clear AJ, Watt J, Wang J, Fatah R, Riches JC, Marshall JF, Chin-Aleong J, Chelala C, Gribben JG, et al. Activated Pancreatic Stellate Cells Sequester CD8(+) T Cells to Reduce Their Infiltration of the Juxtatumoral Compartment of Pancreatic Ductal Adenocarcinoma. Gastroenterology 2013; PMID:23891972; http://dx.doi.org/10.1053/j. gastro.2013.07.025
8. Winau F, Hegasy G, Weiskirchen R, Weber S, Cassan C, Sieling PA, Modlin RL, Liblau RS, Gressner AM, Kaufmann SH. Ito cells are liver-resident antigen-presenting cells for activating T cell responses. Immunity 2007; 26:117-29; PMID:17239632; http://dx.doi. org/10.1016/j.immuni.2006.11.011
9. Bayne LJ, Beatty GL, Jhala N, Clark CE, Rhim AD, Stanger BZ, Vonderheide RH. Tumor-derived granulocyte-macrophage colony-stimulating factor regulates myeloid inflammation and T cell immunity in pancreatic cancer. Cancer Cell 2012; 21:822-35; PMID:22698406; http://dx.doi.org/10.1016/j. ccr.2012.04.025